期刊文献+

VEGF、Ang-2、Tie-2在子宫内膜异位症中的表达及相关性研究 被引量:5

The study of relationship between the expression of VEGF and Ang-2 and Tie-2 in endometriosis
下载PDF
导出
摘要 目的探讨VEGF、Ang-2及Tie-2在EMs患者卵巢异位组织、子宫内膜中的表达。方法收集30例子宫内膜异位症患者的卵巢异位组织及在位内膜组织和30例正常子宫内膜组织,应用免疫组织化学S-P法检测各组织中的VEGF、Ang-2及Tie-2的表达水平。结果 VEGF在正常内膜、EMs在位内膜及异位内膜组织中的表达阳性率逐渐升高(16.67%、86.67%、90.00%),三组比较P<0.01;Ang-2在正常内膜、EMs在位内膜及异位内膜组织中的表达阳性率为(33.33%、70.00%、60.00%),三组比较P<0.05;Tie-2在正常内膜、EMs在位内膜及异位内膜组织中的表达阳性率分别为(13.33%、50.00%、40.00%),三组比较P<0.01;EMs中VEGF、Ang-2、Tie-2三者密切相关(r=0.875、r=0.905、r=0.898)。结论 VEGF、Ang-2、Tie-2的表达与子宫内膜异位症密切相关,可能为子宫内膜异位症的发生发展提供一定的理论依据,为其治疗提供新的靶点。 Objective To detect the expression of VEGF (vascular endothelial growth factor), Ang-2 (angiopoietin-2) and Tie-2 in endometriosis and their correlation with menstrual cycle and clinical stage. Methods The expression of VEGF, Ang-2 and Tie-2 was detected by immunohistochemistry methods. Results The expression of VEGF in the normal endometrium, eutopic endometrium and ectopic endometrium tissues gradually increased the positive rate (16.67%. 86.67%, 90.00%), compared three groups (P〈0.01). The expression of Ang-2 in the normal endometrium, eutopic endometrium and ectopic endometrium tissues the positive rate (33.33%. 70.00%. 60.00%), compared three groups (P〈0.05). The expression of Tie-2 in the normal endometrium, eutopic endometrium and ectopic endometrium tissues the positive rate (13.33%. 50.00%, 40.00%), compared three groups (P〈0.05). The expression ofVEGF, Ang-2 and Tie-2 is closely correlated with each other (t=0.875, r=0.905, r=0.898). Conclusion Our findings suggest that there is a close relation between VEGF, Ang-2 and Tie-2, the up-regulation of VEGF and Ang-2 may cooperatively contribute to survival and invasion of endometriosis. This may provide new targets for therapy of endometriosis.
作者 黄丹丹
出处 《疾病监测与控制》 2014年第12期740-742,共3页 Journal of Diseases Monitor and Control
关键词 血管内皮生长因子 促血管生成素-2 TIE-2 子宫内膜异位症:免疫组织化学 vascular endothelial growth factor angiopoietin-2 Tie-2: endometriosis immunohistochemistry
  • 相关文献

参考文献10

  • 1Giudicelc, Tazuke SI, Swiersz L. status of current research on endometriosis[J].Reprod Med. 1998,43(3 Suppl):252-262.
  • 2Masuda H, Maruyama T, Hiratsu E, et al. Noninvasive and real- time assessment of reconstructed functional human endometrium in NOD/SCID/gammac(null)immunodeficient mice[J]. Proc Natl Acad Sci USA, 2007, 104(6):1925-30.
  • 3Ozawa Y, Murakami T, Tamura M, et aZ Aselective cyclooxygenase-2 inhibitor suppresses the growth of endometriosis xenografts via antiangiogenic activity in severe combined immunodeficiency mice [J].Fertil Steril, 2006,86:1146-51.
  • 4Folkman J, Shing Y. Angiogenesis[J].J Biol chem, 1992,267:l 0931-10934.
  • 5Zeng H, Dvorak HF, Mukhopadhyay D. Vascular permeability factorYPF/vascular endothelial growth factor(VEGF) receptor-i downmodulates VPF/VEGF receptor-2-mediated endothelial cell proliferation, but not migration, through phosphatidylinositol 3-kinase-dependent pathways[J].J Biol Chem, 2001,276(4):26969-26979.
  • 6GoldbergMA, Schneider TJ. Similarities between the oxygen- sensing mechanisms regulating the expression of vascular endothelial growth factor ang reythropietin[J].J Biol Chem, 1994,269:4355-4359.
  • 7Shweiki D, Itin A, Soffer D, et al. Vascular endothelial growth factor by hypoxiamay mediate hypoxia-initiated angiogenesis [J].Nature, 1992,359:843-845.
  • 8Hyder SM, Huang JC, Nawaz Z, et al. Regulation of vascular en- dothelial growth factor expression by estrogens and progestins [J].Environ Health Perspect, 2000,108(5):785-790.
  • 9Terman BI, Dougher-Vermazen M, Carrion ME, et al. Identifica tion of the KDR tyrosine kinase as a receptor for vascul arendothelial growth factor[J]. Biochem Biophys Res Commu n, 1992,187:1579-1586.
  • 10Naufeld G, Cohen T, Gengrinovitch S, et al. Vascular endothelial growth factor(VEGF)and its receptor[J]s. FASEB J, 1999,13: 9-22.

同被引文献37

引证文献5

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部